What Eli Lilly’s new obesity drug Zepbound means for GLP-1 weight-loss medication pricesByLaura BrattonUpdatedDecember 8, 2023
The Supreme Court wrestles with OxyContin maker's bankruptcy deal, with billions of dollars at stakeByMark Sherman, Associated PressUpdatedDecember 4, 2023
OxyContin maker's settlement plan divides victims of opioid crisis. Now it's up to the Supreme CourtByGeoff Mulvihill And Mark Sherman, Associated PressUpdatedNovember 23, 2023
OSHA finds plant explosion that killed 1 person could have been preventedByMichael Casey, Associated PressPublishedNovember 20, 2023
